Wed, April 15, 2020

Matthew Harrison Maintained (UBX) at Buy with Decreased Target to $130 on, Apr 15th, 2020

Matthew Harrison of Morgan Stanley, Maintained "Unity Biotechnology, Inc." (UBX) at Buy with Decreased Target from $140 to $130 on, Apr 15th, 2020.

Matthew, nor any peers, have made any analyst calls on UBX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30